Thromboembolic events in brain tumour patients on bevacizumab
Acta Oncol
.
2020 Dec;59(12):1543-1546.
doi: 10.1080/0284186X.2020.1815834.
Epub 2020 Sep 8.
Authors
Gunjesh Kumar Singh
1
,
Nandini Menon
1
,
Monica Madhusing Jadhav
1
,
Rutuja Walavalkar
1
,
Hollis DSouza
1
,
Somnath Roy
1
,
Sudeep Das
1
,
Sujay Srinivas
1
,
Dilip Harindran Vallathol
1
,
Vijay M Patil
1
Affiliation
1
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India.
PMID:
32897111
DOI:
10.1080/0284186X.2020.1815834
No abstract available
Publication types
Letter
MeSH terms
Angiogenesis Inhibitors / adverse effects
Bevacizumab / adverse effects
Brain Neoplasms* / drug therapy
Humans
Thromboembolism* / chemically induced
Substances
Angiogenesis Inhibitors
Bevacizumab